May 20th 2024
Incorporating dynamic contrast-enhanced MRI, a deep learning model demonstrated a 20 percent higher AUC in external validation testing than clinical factors alone and over a 17 percent higher AUC than radiological factors alone in predicting proliferative hepatocellular carcinoma (HCC).
Can Diffusion-Weighted MRI Have an Impact in Detecting Recurrent Pancreatic Cancer?
May 29th 2022For post-op monitoring of patients who had pancreatic ductal adenocarcinoma (PDAC) resection, a new study showed that diffusion-weighted magnetic resonance imaging (MRI) had enhanced sensitivity for detecting recurrent tumors in comparison to conventional MRI.
Iodinated Contrast Media: 15 Recommendations for Addressing the Shortage
May 12th 2022Given the challenges with the shortage of the iodinated contrast agent Omnipaque, national and state organizations have issued suggested risk mitigation and conservation strategies to reprioritize imaging needs during this temporary shortage.
Issues and Answers With Outsourced Teleradiology Night Coverage
April 28th 2022While there can be an array of challenges in outsourcing night coverage to teleradiology service providers, due diligence with contract terms can help mitigate costs and increase flexibility if radiology practices decide to switch teleradiology providers down the line.